Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Direvo Introduces BluCon™

Published: Friday, November 16, 2012
Last Updated: Friday, November 16, 2012
Bookmark and Share
Conversion of non-food biomass to biofuel and chemical building blocks.

Direvo Industrial Biotechnology GmbH is commercializing its BluCon™ platform for complete, one-step conversion of non-food feedstocks to carbohydrates used in the production of fuels and chemicals.

In the recent years Direvo has undertaken a huge research program identifying a portfolio of proprietary microorganisms, which enable the lowest cost production of valuable chemicals from non-food biomass.

The BluCon™ platform is extremely flexible both for the type of feedstock and the resultant high value fuels and chemicals produced.

BluCon™ converts various non-food biomass ranging from grasses and straw to agricultural and wood residues and can therefore be applied around the globe.

From an end product perspective, BluCon™ delivers transportation fuels like ethanol or chemical building blocks like lactic acid.

“After two years of extremely hard work, we are very excited to use our BluCon™ platform in solving global raw material supply and environmental concerns. Our technology will capture a significant share of the developing bio-based economy”, CEO Jorg Riesmeier explains.

BluCon™ technology platform is a so-called second generation biomass conversion technology. Contrary to first generation technology there is no need to use food feedstocks.

The switch from a fossil-based to a bio-based economy is driven by global warming and by the finite nature of fossil fuels and sustainability.

The gradual switch requires many new technologies at various levels. On a global basis, the demand for transportation fuels and chemical building blocks will continue to increase for foreseeable future.

By 2050 the World Energy Council (WEC) forecasts that global fuel demand could increase as much as 82% compared to 2010 levels. In combination with dwindling public acceptance of fossil-based raw materials, this will lead to a high need for biofuels and bioplastics.

Direvo Industrial Biotechnology GmbH is the only German company and one of very few in Europe developing such a technology.

With decades of experience in “directed evolution” Direvo is perfectly positioned for the final steps of process development along with a network of commercialization partners. These are being carried out partly in house and partly in collaboration with global partners from industry and academia.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

European and US Cellulase Patents Granted to Direvo
Granted patents describe improved cellulase enzymes having CBH II activity.
Wednesday, May 22, 2013
Scientific News
AACR 2016: Cancer Immunotherapy and Beyond
At this year's meeting there was a palpable buzz around subjects ranging from microbiomics to the tumor microenvironment and cancer vaccines, big data to in vitro and in vivo modeling and drug delivery (to name just a few).
How Skeletal Stem Cells Form The Blueprint Of The Face
USC researchers discover that two types of molecular signals work to control where and when stem cells turn into facial cartilage.
Intestinal Worms Boost Immune System In A Surprising Way
EPFL researchers find that intestinal worm infections cause lymph nodes to produce more immune cells as well as grow in size.
Measuring The Airborne Toxicants Urban Bicyclists Inhale
Researchers analyze breath biomarkers to measure uptake of volatile organic compounds by bicyclists.
Breast Milk Hormones Impact Bacteria In Infants’ Guts
Intestinal microbiome of children born to obese mothers significantly different from those born to mothers of healthy weight, CU Anschutz researchers find.
Newborn Screening Test Developed For Rare, Deadly Neurological Disorder
Scientists have developed a new dried blood spot screening test for Niemann-Pick type C, with goal to speed diagnosis and treatment.
'Kidney on a Chip' Facilitates Safer Drug Dosing
University of Michigan researchers have used a "kidney on a chip" device to mimic the flow of medication through human kidneys and measure its effect on kidney cells.
New Autism Blood Biomarker Identified
Researchers at UT Southwestern Medical Center have identified a blood biomarker that may aid in earlier diagnosis of children with autism spectrum disorder, or ASD.
New Method Allows First Look At Embryo Implantation
Researchers at The Rockefeller University develop a method that shows the molecular and cellular processes that occur up to day 14 after fertilization.
Ketamine Metabolism Lifts Depression
NIH-funded team finds rapid-acting, non-addicting agent in mouse study.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!